These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 19804418)

  • 1. Pitfalls of Melan-A staining.
    Andres C; Flaig MJ
    J Cutan Pathol; 2010 Aug; 37(8):917-8. PubMed ID: 19804418
    [No Abstract]   [Full Text] [Related]  

  • 2. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin.
    Beltraminelli H; Shabrawi-Caelen LE; Kerl H; Cerroni L
    Am J Dermatopathol; 2009 May; 31(3):305-8. PubMed ID: 19384076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelanotic vulvar melanoma with intratumor histological heterogeneity.
    Oiso N; Yoshida M; Kawara S; Kawada A
    J Dermatol; 2010 Jun; 37(6):537-41. PubMed ID: 20536668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells.
    Mahmood MN; Lee MW; Linden MD; Nathanson SD; Hornyak TJ; Zarbo RJ
    Mod Pathol; 2002 Dec; 15(12):1288-93. PubMed ID: 12481009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
    Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
    J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistologic markers in the diagnosis and prognosis of malignant melanomas].
    Suter L; Bröcker EB
    Pathologe; 1987 May; 8(3):163-7. PubMed ID: 3303010
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A.
    Helm K; Findeis-Hosey J
    J Cutan Pathol; 2008 Oct; 35(10):931-4. PubMed ID: 18494818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCNA independence of Ki-67 expression in HPV infection.
    Boon ME; Howard CV; van Velzen D
    Cell Biol Int; 1993 Nov; 17(11):1001-4. PubMed ID: 7906585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of necrotic malignant melanomas.
    Nonaka D; Laser J; Tucker R; Melamed J
    Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive sentinel node biopsy in a 30-month-old boy with atypical Spitz tumour (Spitzoid melanoma).
    Urso C; Gelli R; Borgognoni L; Tinacci G; Reali UM
    Histopathology; 2006 Jun; 48(7):884-6. PubMed ID: 16722946
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker.
    Sztramska A; Dymerska D; Chwirot BW
    Melanoma Res; 2008 Aug; 18(4):259-67. PubMed ID: 18626310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage infidelity and expression of melanocytic markers in human breast cancer.
    Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
    Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas.
    Choi C; Kusewitt DF
    Vet Pathol; 2003 Nov; 40(6):713-8. PubMed ID: 14608029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigmented epithelioid melanocytoma.
    Ward JR; Brady SP; Tada H; Levin NA
    Int J Dermatol; 2006 Dec; 45(12):1403-5. PubMed ID: 17184238
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary pulmonary melanoma diagnosis: the role of immunohistochemistry and immunocytochemistry.
    Kotoulas C; Skagias L; Konstantinou G; Tsilalis T; Tsintiris K; Laoutidis G; Sambaziotis D
    J BUON; 2007; 12(4):543-5. PubMed ID: 18067215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Future of malignant stage I melanoma. Immunology and immunotherapy].
    Nicolas JF; Berthier O; Trillet-Lenoir V; Claudy A; Revillard JP
    Ann Dermatol Venereol; 1995; 122(5):324-35. PubMed ID: 8572476
    [No Abstract]   [Full Text] [Related]  

  • 20. The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients.
    Murali R; Thompson JF; Shaw HM; Scolyer RA
    Am J Surg Pathol; 2008 Jul; 32(7):1106-7; author reply 1107-8. PubMed ID: 18521043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.